Case number 1:17-cv-01833
Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 1 | Complaint (12) |
| May 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:17-cv-01833-LPS, 502 in 1:16-cv-00988-LPS, 21 in 1:16-cv-00999-LPS) STIPULATION re Withdrawal of Counterclaims by MSN. Signed by Judge Leonard P. Stark on 5/7/19. Associated Cases: 1:16-cv-00988-LPS, 1:16-cv-00999-LPS, 1:17-cv-01833-LPS (ntl) |
| May 8, 2019 | 16 | Order (3) Docket Text: CONSENT JUDGMENT re MSN, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/7/19. Associated Cases: 1:16-cv-00999-LPS, 1:17-cv-01833-LPS (ntl) |
| May 7, 2019 | 14 | Stipulation (2) Docket Text: STIPULATION re Withdrawal of Counterclaims by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc., MSN Pharmaceuticals Inc.. (Myer, R.) |
| May 7, 2019 | 15 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT with Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited by Onyx Therapeutics, Inc.. (Dellinger, Megan) |
| Jul 13, 2018 | N/A | SO ORDERED (0) |
| Jul 13, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:16-cv-00988-LPS. (ntl) |
| Jul 10, 2018 | 13 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Consolidation by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Jun 26, 2018 | N/A | Order (0) |
| Mar 2, 2018 | 11 | Answer to Counterclaim (7) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Onyx Therapeutics, Inc..(Noreika, Maryellen) |
| Jan 12, 2018 | 8 | Answer to Complaint (16) Docket Text: ANSWER to Complaint , COUNTERCLAIM against Onyx Therapeutics, Inc. by MSN Pharmaceuticals, Inc., MSN Laboratories Private Limited.(Myer, R.) |
| Jan 12, 2018 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by MSN Laboratories Private Limited. (Myer, R.) |
| Jan 12, 2018 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals, Inc. filed by MSN Pharmaceuticals, Inc.. (Myer, R.) |
| Dec 27, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Dec 26, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Onyx Therapeutics, Inc.. MSN Pharmaceuticals, Inc. served on 12/22/2017, answer due 1/12/2018. (Noreika, Maryellen) |
| Dec 26, 2017 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Onyx Therapeutics, Inc.. MSN Laboratories Private Limited served on 12/22/2017, answer due 1/12/2018. (Noreika, Maryellen) |
| Dec 21, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Private Limited on 12/21/2017; MSN Pharmaceuticals, Inc. on 12/21/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Dec 20, 2017 | 1 | Exhibit A (35) |
| Dec 20, 2017 | 1 | Civil Cover Sheet (2) |
| Dec 20, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Dec 20, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/10/2017. Date of Expiration of Patent: 12/7/2027.Thirty Month Stay Deadline: 5/10/2020. (ceg) |
| Dec 20, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,737,112 B2. (ceg) |
| Dec 20, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Onyx Pharmaceuticals, Inc. for Onyx Therapeutics, Inc. filed by Onyx Therapeutics, Inc. (ceg) |
| Dec 20, 2017 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2289091.) - filed by Onyx Therapeutics, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(ceg) |
| Dec 20, 2017 | 1 | Complaint* (1) |
